2026 NPPES data Medical Oncology Physician NPI 1407802895 MD
Verify on CMS →

ALI SHWAIKI, MD

Medical Oncology Physician in MERRIAM, Kansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
507
Medicare Part D claims · 154 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$403.28
3 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ALI SHWAIKI, MD filed 507 Medicare Part D claims in 2023 as a Medical Oncology Physician in MERRIAM, Kansas, prescribing 84% generic.

507
Part D claims, 2023
84%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ALI SHWAIKI, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

507 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

ALI SHWAIKI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ALI SHWAIKI, MD?

Quality data not reported

NPI registry status

Active

Issued 05/26/2006

NPI 1407802895

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

507 26% vs specialty avg

2023 prescription claims

Specialty avg: 689

Specialty distribution in Kansas

How Medical Oncology Physician compares to other specialties among Kansas providers

Kansas providers

Medical Oncology Physician share within Kansas

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within Kansas

Specialty board-certification context

Estimated specialty board-certified rate — Medical Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Medical Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ALI SHWAIKI, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 9100 W 74TH ST, MERRIAM, KS, 66204, with a listed phone of (913) 632-9100. NPI 1407802895 was issued on 05/26/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SHWAIKI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 507 prescription claims written by this provider, covering 154 Medicare beneficiaries and totaling roughly $543K in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 8.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

9100 W 74TH ST
MERRIAM, KS 66204

Provider Details

NPI 1407802895
Specialty Medical Oncology Physician
Credentials MD
Gender Male
NPI Issued 05/26/2006

Hospital and facility affiliations

Facilities where ALI SHWAIKI, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ADVENTHEALTH RANSOM MEMORIAL INC
OTTAWA, KS
SHAWNEE MISSION MEDICAL CENTER INC
OTTAWA, KS

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ALI SHWAIKI, MD. Source: openpaymentsdata.cms.gov.

Total received

$403

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

ALI SHWAIKI, MD — brand share 16.0%
Specialty average (est.)

16% brand-name claims vs 84% generic, on 507 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

507
Total Claims
$543K
Total Drug Cost
154
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
826
Total Day Supply
22,379
Brand vs Generic
16% brand / 84% generic
Brand Drug Cost
$530K
Generic Drug Cost
$13K
Opioid Claims
43 (8.5% rate)
Antibiotic Claims
33

Patient Demographics

Average Patient Age
74.3 years
Avg HCC Risk Score
1.36
Gender Split
73% female / 27% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ALI SHWAIKI, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Anastrozole
91
Letrozole
44
Eliquis
Apixaban
41
Ondansetron Hcl
23
Potassium Chloride
19
Acyclovir
17
Oxycodone Hcl
17
Tamoxifen Citrate
17
Revlimid
Lenalidomide
14
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How ALI SHWAIKI, MD fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

ALI SHWAIKI, MD's 507 claims are below the specialty average of 689.

Nearby Medical Oncology Physician Providers in Kansas

Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as SHWAIKI.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ALI SHWAIKI, MD's specialty?
ALI SHWAIKI, MD specializes in Medical Oncology Physician and practices in MERRIAM, Kansas. Credentials: MD.
How much does ALI SHWAIKI, MD prescribe under Medicare Part D?
In 2023, ALI SHWAIKI, MD wrote 507 Medicare Part D claims totaling $543K in drug costs for 154 beneficiaries.
Where is ALI SHWAIKI, MD located?
ALI SHWAIKI, MD is located at 9100 W 74TH ST, MERRIAM, KS, 66204. Phone: (913) 632-9100.
What is ALI SHWAIKI, MD's NPI number?
ALI SHWAIKI, MD's National Provider Identifier (NPI) is 1407802895, issued on 05/26/2006.
Does ALI SHWAIKI, MD prescribe more brand-name or generic drugs?
ALI SHWAIKI, MD's prescribing is 16% brand-name and 84% generic drugs by claim count, with $530K in brand drug costs.
Does ALI SHWAIKI, MD prescribe opioids?
Yes, ALI SHWAIKI, MD had 43 opioid claims in 2023 with an opioid prescribing rate of 8.5%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does ALI SHWAIKI, MD prescribe most often?
Based on 2023 Medicare Part D data, ALI SHWAIKI, MD's most frequently prescribed drugs include Anastrozole, Letrozole, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ALI SHWAIKI, MD accept Medicare?
ALI SHWAIKI, MD appears in CMS Medicare data with 507 Part D claims and 154 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ALI SHWAIKI, MD's credentials?
ALI SHWAIKI, MD's NPI is 1407802895 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology